Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
94.32
+2.61 (2.85%)
At close: Jul 21, 2026, 4:00 PM EDT
95.75
+1.43 (1.52%)
After-hours: Jul 21, 2026, 7:16 PM EDT
Oruka Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $151 | Buy | Maintains | $151 | +60.09% | Jul 14, 2026 |
| UBS | UBS | Buy Reiterates $100 → $130 | Buy | Reiterates | $100 → $130 | +37.83% | Jul 1, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $150 | Buy | Maintains | $150 | +59.03% | Jun 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +27.23% | Jun 23, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $180 | Buy | Maintains | $180 | +90.84% | Jun 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 2, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $125 | Buy | Maintains | $125 | +32.53% | May 23, 2026 |
| Wedbush | Wedbush | Buy Maintains $165 | Buy | Maintains | $165 | +74.94% | May 14, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.